Lessons for IoT from 8 F1 Championships
•Download as PPTX, PDF•
3 likes•1,897 views
McLaren Applied Technologies uses data and analytics from Formula 1 racing to develop IoT solutions. They use real-time data collection, predictive analytics, and visualization to optimize race strategy. McLaren is now applying these skills to develop smart systems for production line optimization, medical devices, surgical wearables, and personalized healthcare.
Recommended
Recommended
More Related Content
Similar to Lessons for IoT from 8 F1 Championships
Similar to Lessons for IoT from 8 F1 Championships (20)
More from Business of Software Conference
More from Business of Software Conference (20)
Recently uploaded
Recently uploaded (20)
Lessons for IoT from 8 F1 Championships
- 1. McLAREN APPLIED TECHNOLOGIES 1 LESSONS FOR THE IoT FROM 8 WORLD CHAMPIONSHIPS CAROLINE HARGROVE TECHNICAL DIRECTOR IoT 2015 11-12 March 2015, Cambridge
- 2. WHAT WE’RE ABOUT: OUR PROMISE DATA UNDERPINS EVERYTHING WE DO McLAREN APPLIED TECHNOLOGIES 2
- 3. McLAREN APPLIED TECHNOLOGIES McLAREN RACING DATA CYCLE SIMULATION AND SIMULATOR DESIGN PRE-RACE ANALYSIS LIVE MONITORING AND STRATEGY POST-RACE ANALYSIS DATA MANAGEMENT AND VISUALISATION PERFORMANCE AND COMPETITOR ANALYSIS CONCEPTS & DESIGN ANALYSIS ADVANCED TELEMETRY REAL-TIME DATA SETUP AND STRATEGY OPTIMISATION
- 4. McLAREN APPLIED TECHNOLOGIES IMMERSIVE ENVIRONMENTS: INTERACTIVE CAR DEVELOPMENT
- 5. WHAT WE’RE ABOUT: OUR PROMISE FOCUS AREAS: SIMULATION SYSTEMS McLAREN APPLIED TECHNOLOGIES Race Trace: 08Canada10 - 13/06/10 - Race Lap Number 706050403020100 TimeGap(seconds) 40 30 20 10 0 -10 -20 -30 -40 1:BUT(2nd) 2:HAM(1st) 4:ROS(6th) 5:VET(4th) 6:WEB(5th) 8:ALO(3rd) 11:KUB(7th) 23:KOB 3:MSC(11th) 7:MAS(15th) 9:BAR(14th) 10:HUL(13th) 14:SUT(10th) 15:LIU(9th) 16:BUE(8th) 17:ALG(12th) 21:SEN 22:DLR 12:PET(17th) 19:KOV(16th) 12:PET(17th) 18:TRU 19:KOV(16th) 24:GLO 20:CHD(18th) 25:DIG(19th) Option Prim e Prime Option Prim e Prime Prime Prime Option Prim e Prime Prime Option Prime Prime Prim e Option Option Prim e Prime Option Prim e Prime Prime Prime Prime Prime Option Option Prime Prime Prime Prime Option Prim e O ption Prim e Prim e Prim e Prim e Prim e Stops 1 Lap 15 Prime PREDICTIVE ANALYTICS: REAL-TIME RACE STRATEGY
- 6. WHAT WE’RE ABOUT: OUR PROMISE VISUALISATION: CONSUMING COMPLEX DATA IN REAL-TIME McLAREN APPLIED TECHNOLOGIES
- 7. SMART SYSTEMS: ANALYSING DATA TO ANTICIPATE & REACT IN REAL-TIME McLAREN APPLIED TECHNOLOGIES
- 8. McLAREN APPLIED TECHNOLOGIES SMART SYSTEMS: DYNAMIC SCHEDULING FOR PRODUCTION LINE OPTIMISATION
- 9. COMPLEX DECISION- MAKING: SUPPORTING SKILL OPERATORS UNDER PRESSURE McLAREN APPLIED TECHNOLOGIES
- 10. McLAREN APPLIED TECHNOLOGIES DECISION SUPPORT SYSTEMS: AIR TRAFFIC CONTROL
- 11. MEDICAL DEVICES WITH INTELLIGENCE INSIDE: IMPROVING QUALITY OF DELIVERY TO PATIENT McLAREN APPLIED TECHNOLOGIES
- 12. SURGICAL WEARABLES: ASSESSING PERFORMANCE OF TRAINEE SURGEONS McLAREN APPLIED TECHNOLOGIES
- 13. PERSONALISED CARE: ANALYSE DATA TO ADAPT IN REAL TIME McLAREN APPLIED TECHNOLOGIES
- 14. SURGICAL ENVIROMENTS FUTURE OF MEDICAL OPERATING THEATRES INTELLIGENT MEDICAL ENVIRONMENT? McLAREN APPLIED TECHNOLOGIES
Editor's Notes
- Image not ours GSK Ventalin MDI shake characteristics Miniature, hi-res activity classification helps define the best way to mix a compound to FDA standards. Integrated into drug pack aerosol. Can be used in the field for patient data collection Clinical benefit - Characterisation of ideal mixing profile helps treatment meet FDA quality requirements on manufacturing line. Ability to collect real patient user data and feedback informative, educational information to improve treatment Financial benefit – GSK currently spend £11m pa in trying to meet quality requirements related to mixing (or lack of understanding of). GSK spending £7m on mixing rigs without calibration equipment Why McLaren – DoE. Experts in deriving behavioural insight from time series data (humans). Design of feedback mechanisms and data insight to patient and physician. Ability to deliver end to end systems appropriate to need. Design and innovation of next generation intelligent devices – product design, fluid analysis and mechanical design.
- ElectroBiology Therapies (pure and advanced R&D) Clinical benefit - Non chemical treatment, ability to have large and direct impact on conditions linked to organ dysfunction. Potentially large impact on quality of life Financial benefit – Replaces certain medicines/treatments, reduced dependency on other devices and treatments Why McLaren – Ability to derive insight from complex signals. Ability to simulate ionic signals to stimulate organs. Expertise in design and engineering of bespoke and innovative nerve sensors In 20 years treatment and therapies will include stimulation and simulation of ionic charge signals to supplement the control of lost organ control. Pioneered in rat bladder control. McLaren discussing signal processing and sensor design with GSK of this new thearapy
- Collaboration with Oxford Medical School to build a use a future operating theatre. Clinical benefit - Future visions brought to reality, ultimately driving at improved patient experience through increase operational efficiencies Financial benefit – Cost of care Why McLaren – Direct parallels with design of simulator, F1 systems, data handling and integration, data display, connected health ecosystems, device design, structural design, aesthetics, operational excellance.